ACRS · All filings · Read this filing
What changed 10-K
Item 5. Market for Registrant’s Common Equity
2023-02-23 compared with 2022-02-24 · 1 added, 2 removed, 18 unchanged (14% of the section changed)
14 unchanged sentences
The stock price performance shown on the graph below is based on historical data and is not indicative of future stock price performance.
−Removed: The graph and table below shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities under that Section, and shall not be deemed to be
−Removed: incorporated by reference into any of our filings under the Securities Act or the Exchange Act.
+Added: The graph and table below shall not be deemed “soliciting material” or to be “filed” with the SEC for purposes of Section 18 of the Exchange Act or otherwise subject to the liabilities under that Section, and shall not be deemed to be incorporated by reference into any of our filings under the Securities Act or the Exchange Act.
Aclaris Therapeutics, Inc.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.